Lack of follow-up colonoscopy after positive FOBT in an organized colorectal cancer screening program is associated with modifiable health care practices

Preventive Medicine

Volumn 76, Issue , 2015, Pages 115-122

  Correia, Adriano ^h   Rabeneck, Linda ^a,b,c,d,e   Baxter, Nancy N ^b,d,f,g   Paszat, Lawrence F ^a,b,c   Sutradhar, Rinku ^b,c   Yun, Lingsong ^b   Tinmouth, Jill ^a,b,d,e,g  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CANCER CARE ONTARIO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h CREDIT VALLEY HOSPITAL   (Canada)

Author keywords

Colonoscopy; Colorectal cancer; Fecal occult blood testing; Organized screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE PRACTICE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCULT BLOOD TEST; PHYSICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; URBAN AREA; CANADA; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; MASS SCREENING; OCCULT BLOOD; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

GUAIAC;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GUAIAC; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; ONTARIO; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84928941112     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2015.03.028     Document Type: Article

References (42)

1. Alharbi O., Rabeneck L., Sutradhar R., et al. A population-based analysis of outpatient colonoscopy in adults assisted by an anesthesiologist. Anesthesiology 2009, 111:734-740.
2. Anonymous The Australian Bowel Cancer Screening Program and beyond: final evaluation report (Date accessed: Screening Monograph No. 6/2005). http://www.health.gov.au/internet/screening/publishing.nsf/Content/2DDFA95B20302107CA2574EB007F7408/$File/final-eval.pdf.
3. Anonymous The Johns Hopkins University ACG Case-Mix System. Johns Hopkins Bloomberg School of Public Health (Date accessed: Aug 13, 2013). http://www.acg.jhsph.edu/.
4. Anonymous Ontario's Local Health Integration Networks. Ontario Ministry of Health and Long Term Care (Date accessed: Aug 13, 2013). http://www.lhins.on.ca/home.aspx.
5. Austin P.C., van Walraven C., Wodchis W.P., Newman A., Anderson G.M. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med. Care 2011, 49:932-939.
6. Baig N., Myers R.E., Turner B.J., et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am. J. Gastroenterol. 2003, 98:2078-2081.
7. Canadian Cancer Society's Steering Committee on Cancer Statistics Canadian Cancer Statistics 2013 2013, Canadian Cancer Society, Toronto, ON, (http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/canadian-cancer-statistics-2013-EN.pdf.).
8. Carlson C.M., Kirby K.A., Casadei M.A., Partin M.R., Kistler C.E., Walter L.C. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?. Arch. Intern. Med. 2011, 171:249-256.
9. Chilton A., Rutter M. Quality assurance guidelines for colonoscopy. National Health Service Cancer Screening Programmes http://www.cancerscreening.nhs.uk/bowel/publications/nhsbcsp06.pdf.
10. Choi K.S., Lee H.Y., Jun J.K., Shin A., Park E.C. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008. J. Gastroenterol. Hepatol. 2012, 27:1070-1077.
11. European Commission European guidelines for quality assurance in colorectal cancer screening and diagnosis. International Agency for Research on Cancer Luxembourg 2010, (http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start;pgid=y8dIS7GUWMdSR0EAlMEUUsWb00003cwwKX6s;sid=-Xdr61JYrdZr6x8iv9_1TDB9_qRtOB875wU=?PublicationKey=ND3210390.). first ed. N. Segnan, J. Patnick, L. von Karsa (Eds.).
12. Ferrat E., Le Breton J., Veerabudun K., et al. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br. J. Cancer 2013, 109:1437-1444.
13. Fisher D.A., Jeffreys A., Coffman C.J., Fasanella K. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1232-1235.
14. Gellad Z.F., Almirall D., Provenzale D., et al. Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia. Dig. Dis. Sci. 2009, 54:2497-2502.
15. Glazier R.H., Klein-Geltink J., Kopp A., Sibley L.M. Capitation and enhanced fee-for-service models for primary care reform: a population-based evaluation. Can. Med. Assoc. J. 2009, 180:E72-E81.
16. Glazier R.H., Zagorski B.M., Rayner J. Comparison of Primary Care Models in Ontario by Demographics, Case Mix and Emergency Department Use, 2008/09 to 2009/10 2012, ICES Investigative Report. Institute for Clinical Evaluative Sciences, Toronto.
17. Grimes D.A., Schulz K.F. Bias and causal associations in observational research. Lancet 2002, 359:248-252.
18. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
19. HealthForceOntario Family Practice Models. Government of Ontario (Date accessed: Aug 13, 2013). http://www.healthforceontario.ca/Work/OutsideOntario/PhysiciansOutsideOntario/PractisingInOntario/family_practice:models.aspx.
20. Jaakkimainen L., Klein-Geltink J.E., Guttman A., et al. Indicators of primary care based on administrative data. Primary Care in Ontario: ICES Atlas 2006, Institute for Clinical Evaluative Sciences, Toronto. L. Jaakkimainen, R. Upshur, J.E. Klein-Geltink, A. Leong, S. Maaten, S.E. Schultz, L. Wang (Eds.).
21. James P.D., Wilkins R., Detsky A.S., Tugwell P., Manuel D.G. Avoidable mortality by neighbourhood income in Canada: 25years after the establishment of universal health insurance. J. Epidemiol. Community Health 2007, 61:287-296.
22. Jimbo M., Myers R.E., Meyer B., et al. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation. Ann. Fam. Med. 2009, 7:11-16.
23. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471.
24. Liang K., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
25. Logan R.F., Patnick J., Nickerson C., et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012, 61:1439-1446.
26. Lurie J.D., Welch H.G. Diagnostic testing following fecal occult blood screening in the elderly. J. Natl. Cancer Inst. 1999, 91:1641-1646.
27. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 1993, 328:1365-1371.
28. Miles A., Cockburn J., Smith R.A., Wardle J. A perspective from countries using organized screening programs. Cancer 2004, 104:1201-1213.
29. Morris S., Baio G., Kendall E., et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. Br. J. Cancer 2012, 107:765-771.
30. Moss S.M., Campbell C., Melia J., et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012, 61:101-107.
31. Nadel M.R., Shapiro J.A., Klabunde C.N., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann. Intern. Med. 2005, 142:86-94.
32. Nadel M.R., Berkowitz Z., Klabunde C.N., Smith R.A., Coughlin S.S., White M.C. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J. Gen. Intern. Med. 2010, 25:833-839.
33. Paszat L., Rabeneck L., Kiefer L., et al. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project. Can. J. Gastroenterol. 2007, 21:379-382.
34. Rabeneck L., Zwaal C., Goodman J.H., Mai V., Zamkanei M. Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: evidentiary base and recommendations. Clin. Biochem. 2008, 41:1289-1305.
35. Rabeneck L., Paszat L.F., Saskin R., Stukel T.A. Association between colonoscopy rates and colorectal cancer mortality. Am. J. Gastroenterol. 2010, 105:1627-1632.
36. Rao S.K., Schilling T.F., Sequist T.D. Challenges in the management of positive fecal occult blood tests. J. Gen. Intern. Med. 2009, 24:356-360.
37. Ray J.G., Vermeulen M.J., Schull M.J., Singh G., Shah R., Redelmeier D.A. Results of the Recent Immigrant Pregnancy and Perinatal Long-term Evaluation Study (RIPPLES). Can. Med. Assoc. J. 2007, 176:1419-1426.
38. Robles S.C., Marrett L.D., Clarke E.A., Risch H.A. An application of capture-recapture methods to the estimation of completeness of cancer registration. J. Clin. Epidemiol. 1988, 41:495-501.
39. Shields H.M., Weiner M.S., Henry D.R., et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. Am. J. Gastroenterol. 2001, 96:196-203.
40. Steele R.J., Kostourou I., McClements P., et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J. Med. Screen. 2010, 17:68-74.
41. Turner B., Myers R.E., Hyslop T., et al. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. J. Gen. Intern. Med. 2003, 18:357-363.
42. Van Kleek E., Liu S., Conn L.M., Hoadley A., Ho S.B. Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests. J. Healthc. Qual. 2010, 32:62-69.